R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Executive Director - Head of Strategy & Transformation

IT OperationsPosted on Nov 11
Full-time$255k - $424.9k /yr

About the Job

Requirements

  • You have led strategy, planning, or transformation for a large infrastructure or technology organization and owned the results.
  • You have built and run a technology investment portfolio, deciding what gets funded when resources are tight and demands compete.
  • You have delivered large, complex transformation programs that crossed organizational lines, not just individual projects.
  • You know enough about cloud, network, compute, and platforms to set direction and standards that hold up under scrutiny.
  • You understand how security and AI reshape an enterprise estate, and you can set strategy and standards for both while partnering well with the security organization.
  • You build alignment across senior stakeholders and can drive decisions without relying on direct authority.
  • You have worked in pharma, biotech, or life sciences, with exposure to GxP, regulated environments, or global manufacturing.
  • You have operated in a global company with central strategy and distributed delivery.
  • Bachelor’s degree in information technology, Computer Science, Engineering, Information Management, or a related field.
  • 15+ years in enterprise infrastructure or technology, with real depth in strategy, portfolio management, and transformation, and exposure to security and AI at enterprise scale.
  • 5+ years leading a strategy, portfolio, or transformation function, including managing people at the Director or Senior Manager level.
  • 3+ years owning portfolio prioritization and investment decisions in a complex, multi-domain environment.
  • A track record leading cross-functional programs with finance, delivery, and senior business stakeholders.

Responsibilities

  • Assist in setting the multi-year strategy and architectural direction for GTEO, translating enterprise priorities into a funded roadmap and setting standards that guide investment and modernization.
  • Own the investment portfolio and the budget end to end, prioritizing and funding against business value and capacity.
  • Lead major transformation programs from strategy through delivered value, accountable for the business case and committed benefits.
  • Own and shape capacity allocation so the roadmap can be funded, staffed, and sequenced; procurement and delivery teams own contracts and execution.
  • Set direction on technology lifecycle, refresh, and technical-debt retirement as part of the roadmap, with delivery teams owning execution.
  • Prioritize and fund transformation initiatives sourced from Business Process Excellence & User Experience process and experience redesigns and Enterprise Architecture’s technology roadmap.
  • Build security and resilience into strategy and architecture from the start, setting standards in partnership with the CISO organization, which owns security operations and policy.
  • Set the strategy for AI adoption across GTEO, including platforms, guardrails, and operating model, so the organization scales AI safely and achieves value.
  • Build and structure the transformation functions across strategy, architecture, portfolio, and operations.
  • Partner with senior leaders across Research, Commercial, IOPS, and the India GCC, and advise technology leadership to keep organizational strategy tied to the business and execution aligned to the roadmap.
  • Represent the program to executive stakeholders with clear reporting, metrics, and audit-ready governance, and benchmark against industry peers.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs